Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01326910 · ClinicalTrials.gov registry record · NA
Human Testing of an Over-the-Counter (OTC) Cream in Children With Eczema
A NA study, sponsored by Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT01326910: Completed NA study, sponsored by Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies.
NCT01326910 is a NA study that has completed, run by Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies. The registered enrollment target is 90 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01326910, a NA study, has completed, sponsored by Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
This three week study will be conducted to determine the safety and efficacy of an over-the-counter (OTC) cream in children with mild to moderate atopic dermatitis.
Primary Outcome
A regional body surface area tabulation based on severity ranging from 0 (none) to 3 (severe), and severity of signs of disease, then multiplied by body area with final calculation ranging from 0-72
Interventions
- DRUG Colloidal Oatmeal
- DEVICE Topical Cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2011-03 |
| Est. Completion | 2011-06 |
| Phase | NA |
Sponsor
Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies4 total trials
What the finished NCT01326910 record still lists
NCT01326910 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Colloidal Oatmeal is the first listed.
NCT01326910 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01326910 about?
NCT01326910 is a clinical study titled "Human Testing of an Over-the-Counter (OTC) Cream in Children With Eczema". This three week study will be conducted to determine the safety and efficacy of an over-the-counter (OTC) cream in children with mild to moderate atopic dermatitis.
What is the current status of trial NCT01326910?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2011-03. Estimated completion is 2011-06.
What interventions are being tested in trial NCT01326910?
The interventions under investigation include: Colloidal Oatmeal (DRUG), Topical Cream (DEVICE).
Who is sponsoring clinical trial NCT01326910?
This trial is sponsored by Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01326910's enrollment target sits among peer trials
90 941st of 2000 higher than 1,029 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia